CHEMOMAB THERAPEUTICS LTD's ticker is CMMB and the CUSIP is 16385C104. A total of 12 filers reported holding CHEMOMAB THERAPEUTICS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,241,274 | $2,005,940 | 0.04% |
| Ikarian Capital, LLC | 213,392 | $190,986 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 26,529 | $23,743 | 0.00% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 31,241 | $27,961 | 0.00% |
| Qube Research & Technologies Ltd | 44 | $39 | 0.00% |
| Moser Wealth Advisors, LLC | 500 | $448 | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,100 | $985 | 0.00% |
| UBS Group AG | 141 | $126 | 0.00% |
| RHUMBLINE ADVISERS | 2,843 | $2,542 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,775 | $1,587 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 11,737 | $10,504 | 0.00% |
External links
This page lists CHEMOMAB THERAPEUTICS LTD's shareholders in Q3 2023. To view CHEMOMAB THERAPEUTICS LTD's shareholder history, click here.